Related Experiment Videos
Mast cells, eosinophils and fibrosis
1Department of Pharmacology, School of Pharmacy, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Summary
Mast cells (MC) and eosinophils (EOS) directly impact fibrotic processes by influencing fibroblast proliferation and collagen synthesis. MC activation in chronic graft-versus-host disease (cGVHD) is harmful, suggesting MC stabilization as a potential therapy.
Area of Science:
- Immunology
- Cell Biology
- Fibrosis Research
Background:
- Fibrotic diseases are characterized by excessive collagen deposition and tissue remodeling.
- The roles of mast cells (MC) and eosinophils (EOS) in modulating fibrosis remain incompletely understood.
- Inflammatory cell involvement in fibroblast behavior is crucial for understanding fibrotic pathogenesis.
Purpose of the Study:
- To elucidate the specific roles of MC and EOS in modulating fibrotic processes.
- To investigate the impact of MC and EOS interactions on human fibroblast properties.
- To evaluate the therapeutic potential of MC stabilization in fibrotic conditions like cGVHD.
Main Methods:
- In vitro studies using human fibroblasts from various anatomical locations.
- In vivo studies in murine and human chronic graft-versus-host disease (cGVHD) models.
- Assessment of fibroblast proliferation and collagen synthesis modulated by MC and EOS.
Main Results:
- MC and EOS directly enhance fibroblast proliferation and differentially regulate collagen synthesis in vitro.
- Interactions between MC and EOS significantly modulate fibrotic processes.
- MC activation is detrimental in vivo in cGVHD models, indicating a pro-fibrotic role.
Conclusions:
- MC and EOS are key modulators of fibrotic processes, influencing fibroblast behavior.
- MC activation contributes to fibrosis in cGVHD, suggesting MC stabilization as a therapeutic strategy.
- Further research is needed to identify specific mediators and therapeutic targets for fibrotic diseases.